Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Myelodysplastic-Myeloproliferative Diseases × regorafenib × 90 days × Clear all

Sponsor

Conditions

Colorectal Neoplasms 15 Carcinoma, Hepatocellular 4 Sarcoma, Ewing 3 Sarcoma 2 Glioblastoma 2 Esophageal Neoplasms 2 Colonic Neoplasms 2 Uterine Cervical Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Malignant Tumors 1 Small Cell Lung Carcinoma 1 Rectal Neoplasms 1 Patient Compliance 1 Pathologic Complete Response 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Osteosarcoma 1 Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Melanoma 1 MSI-H Colorectal Cancer 1 Lymphoma, Non-Hodgkin 1 Liver Neoplasms 1 Liver Metastasis Colon Cancer 1 Leukemia, Myeloid, Acute 1 Leiomyosarcoma 1 Histiocytoma, Malignant Fibrous 1 Hemangiosarcoma 1 HER2-positive Colorectal Cancer 1

Interventions

Specimen Handling 7 Biopsy 6 fludarabine 3 ruxolitinib 2 decitabine and cedazuridine drug combination 2 Tacrolimus 2 Injections 2 Decitabine 2 Cyclophosphamide 2 Busulfan 2 Azacitidine 2 venetoclax 1 veliparib 1 tagraxofusp 1 posaconazole 1 peginterferon alfa-2b 1 onvansertib 1 merphos 1 iadademstat 1 fludarabine phosphate 1 fedratinib 1 axatilimab 1 Topotecan 1 Thiotepa 1 Succimer 1 Stem Cell Transplantation 1 Pentetic Acid 1 Mycophenolic Acid 1 Methotrexate 1 Melphalan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡